PSKW Names Ticia Cawley Vice President, Specialty Programs
PSKW, LLC, a leading provider of biopharma loyalty relationship marketing services, announced today that Ticia Cawley has been named Vice President of Specialty Programs.
Ms. Cawley is an integral part of PSKW’s innovation in specialty pharmaceuticals co-pay offset programs. A passionate and results-oriented biotech professional, she is frequently acknowledged by clients and co-workers for her in-depth knowledge of biologics honed during her tenure at Genzyme and UCB. In her new position, Ticia will oversee multiple aspects of PSKW’s specialty pharmaceuticals business, including developing new specialty offerings for the industry, providing technical and consultative support to PSKW’s business development team, and representing the company at specialty pharmaceuticals industry conferences and advisory boards.
“Ticia’s energy and dedication are absolutely infectious,” notes Steve Freeman, PSKW President. “She is a powerful force within our organization, an individual who raises the bar for all of us. PSKW is extremely fortunate to have Ticia on our team.”
Ms. Cawley earned her BS from Northwestern University in Evanston, IL, and her BSN from Salem State College in Salem, MA, graduating magna cum laude. She received the Genzyme Global Marketing Vice President’s Award in 2001, and was honored in 2012 as an industry Rising Star by the Healthcare Businesswomen’s Association (HBA).
Specialty products represent a growing share of PSKW’s business and provide a special niche with regard to co-pay assistance programming. The pipeline for specialty products is robust, with over 600 products either on the market or in active development. It is estimated that spending on specialty pharmaceuticals will climb to more than 40 percent of total drug spend by 2030. Under Ms. Cawley’s leadership, PSKW will continue to provide innovative specialty pharmaceuticals co-pay programs to the biopharma marketplace.
- Contact Information
- Steve Crow
- Marketing Communications
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.